Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046941 · ClinicalTrials.gov registry record · NA
Brain Biomarkers of Response to Treatment for Apraxia of Speech
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02046941: Completed NA study, sponsored by VA Office of Research and Development.
NCT02046941 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02046941, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The study will use MRI brain imaging to identify brain changes associated in stroke patients after they receive speech-language treatment for their speech difficulties.
Interventions
- BEHAVIORAL Speech Production Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-03-01 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02046941
The ClinicalTrials.gov registry entry for NCT02046941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Speech Production Treatment is the first listed.
NCT02046941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02046941 about?
NCT02046941 is a clinical study titled "Brain Biomarkers of Response to Treatment for Apraxia of Speech". The study will use MRI brain imaging to identify brain changes associated in stroke patients after they receive speech-language treatment for their speech difficulties.
What is the current status of trial NCT02046941?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-03-01. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT02046941?
The interventions under investigation include: Speech Production Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02046941?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.